uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Improved outcome from substituting methotrexate with epirubicin: results from a randomised comparison of CMF versus CEF in patients with primary breast cancer
Show others and affiliations
2007 (English)In: European Journal of Cancer, ISSN 0959-8049, Vol. 43, no 5, 877-884 p.Article in journal (Refereed) Published
Abstract [en]

We compared the efficacy of CEF (cyclophosphamide, epirubicin, and fluorouracil) against CMF (cyclophosphamide, methotrexate, and fluorouracil) in moderate or high risk breast cancer patients. We randomly assigned 1224 patients with completely resected unilateral breast cancer to receive nine cycles of three-weekly intravenous CMF or CEF. Patients were encouraged to take part in a parallel trial comparing oral pamidronate 150 mg twice daily for 4 years versus control (data not shown). Substitution of methotrexate with epirubicin significantly reduced the unadjusted hazard for disease-free survival (DFS) by 16% (hazard ratio 0.84; 95% CI; 0.71-0.99) and for overall survival by 21% (hazard ratio 0.79; 95% CI; 0.66-0.94). The risk of secondary leukaemia and congestive heart failure was similar in the two groups. Overall CEF was superior over CMF in terms of DFS and OS in patients with operable breast cancer without subsequent increase in late toxicities.

Place, publisher, year, edition, pages
2007. Vol. 43, no 5, 877-884 p.
Keyword [en]
Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/administration & dosage/*therapeutic use, Breast Neoplasms/*drug therapy, Cyclophosphamide/administration & dosage, Cytarabine/administration & dosage, Epirubicin/administration & dosage, Female, Fluorouracil/administration & dosage, Humans, Methotrexate/administration & dosage, Middle Aged, Treatment Outcome
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-15230DOI: 10.1016/j.ejca.2007.01.009PubMedID: 17306974OAI: oai:DiVA.org:uu-15230DiVA: diva2:43001
Available from: 2008-02-07 Created: 2008-02-07 Last updated: 2010-04-22Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=17306974&dopt=Citation
By organisation
Centre for Research and Development, Gävleborg
In the same journal
European Journal of Cancer
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 203 hits
ReferencesLink to record
Permanent link

Direct link